Skip to content
Clinical Trials – home

Sarcoma Life with Disease

8 / 11 trials open to patients4 countries

In short

Sarcoma is a rare group of cancers that develop in the bones and soft tissues of the body, including muscles, fat, blood vessels, nerves, and other connective tissues that support and surround our organs. While these cancers can appear anywhere in the body and affect people of all ages, understanding what lies ahead and how to navigate life with this diagnosis can help patients and their families face the journey with greater confidence and preparedness.

Key points

  • Sarcomas are rare but serious cancers affecting connective tissues throughout the body, with over 70 different subtypes that behave differently
  • When caught before spreading, soft tissue sarcoma has an 83% five-year survival rate, emphasizing the critical importance of early detection
  • Treatment at specialized sarcoma centers that handle at least 50 cases yearly dramatically improves outcomes compared to general cancer centers
  • Physical changes from treatment, including surgical scars and functional limitations, can deeply affect self-image and emotional well-being, but support and rehabilitation help
  • Sarcomas have a frustrating tendency to recur even after apparently successful treatment, making long-term monitoring essential
  • Clinical trials offer access to cutting-edge treatments and are conducted under strict ethical guidelines with the option to withdraw at any time
  • Family members play a vital role in supporting patients through clinical trial participation, from research and logistics to emotional encouragement
  • Rehabilitation services including physical therapy, occupational therapy, and specialized lymphedema treatment significantly improve quality of life after sarcoma treatment

Understanding What to Expect: Prognosis

When you receive a diagnosis of sarcoma, one of the first questions that naturally comes to mind is what the future holds. The outlook for people with sarcoma varies significantly depending on several important factors, and it's essential to understand that each person's journey is unique.

For soft tissue sarcoma, survival rates offer some perspective but should not be seen as definitive predictions for any individual. According to available data, when soft tissue sarcoma is discovered before it has spread to other parts of the body, the five-year relative survival rate is approximately 83%. This means that people with localized sarcoma have an 83% chance of living at least five years compared to people of the same age without cancer. What's particularly encouraging is that ten-year survival rates remain similar, suggesting that those who survive five years are likely to have long-term disease control.

The overall relative five-year survival rate for people with sarcoma sits around 50%. However, this number encompasses all stages and types of sarcoma. When sarcoma begins in an arm or leg, survival rates tend to be higher for each stage compared to sarcomas that start in other locations like the chest, abdomen, or head and neck.

Several factors influence prognosis beyond just the location of the tumor. The type of sarcoma matters significantly, as there are more than 70 different subtypes, each with its own characteristics and behavior patterns. The stage at diagnosis is crucial—whether the cancer is confined to its original site or has spread to lymph nodes or distant organs makes a substantial difference. The size of the tumor, how quickly the cancer cells are dividing (known as the grade), and your overall health and age all play roles in determining outcomes.

It's important to remember that sarcomas are notorious for their tendency to recur and spread to other parts of the body, even after what appears to be complete surgical removal. This characteristic makes ongoing monitoring and follow-up care absolutely essential. Between 25% and 50% of patients treated with conventional methods may still develop disease that has spread to other organs, which presents additional treatment challenges.

How Sarcoma Develops Without Treatment: Natural Progression

Understanding how sarcoma behaves when left untreated helps explain why prompt diagnosis and treatment are so important. Sarcomas begin when certain cells in bone or soft tissue undergo changes in their DNA—the genetic instruction manual that tells cells what to do. In healthy cells, DNA instructs them to grow, multiply, and die in an orderly, controlled manner. When sarcoma develops, these instructions become corrupted.

The altered cells begin to grow and multiply in an unregulated way, ignoring the normal signals that would tell them to stop dividing or die. Over time, these abnormal cells accumulate and form a mass or tumor. This tumor doesn't just sit still—it actively invades nearby healthy tissues, pushing into and destroying the normal structures around it. The cancer cells can break away from the primary tumor and enter the bloodstream or lymphatic system, traveling to distant parts of the body where they establish new tumors. This process is called metastasis.

Without treatment, sarcomas typically grow larger and more invasive. Soft tissue sarcomas can grow quite quickly, though the speed varies depending on the specific type of cancer and individual factors. As the tumor expands, it may press on nerves, blood vessels, or organs, causing increasing pain and dysfunction in the affected area. A sarcoma in a limb might eventually interfere with movement or sensation. One in the abdomen could compress vital organs or blood vessels, leading to serious complications.

The lungs are a particularly common site for sarcoma to spread, as cancer cells traveling through the bloodstream often lodge there. When sarcoma metastasizes to distant organs, it becomes much more challenging to treat. At this advanced stage, the cancer can affect multiple organ systems simultaneously, and complete responses to treatment become quite rare.

The progression from localized disease to widespread cancer emphasizes why early detection and treatment are so critical. Sarcomas are generally easier to treat successfully when caught before they have spread beyond their original location. This is why any unusual lump, persistent pain, or unexplained symptoms should prompt a medical evaluation, especially if these symptoms persist or worsen over time.

Possible Complications

Living with sarcoma brings the potential for various complications, both from the disease itself and from the treatments used to fight it. Understanding these possibilities can help you recognize warning signs early and seek appropriate care when needed.

One of the most serious complications is the spread of cancer to other parts of the body. When sarcoma cells break away from the primary tumor and establish new growth sites, they most commonly travel to the lungs. This pulmonary metastasis can cause breathing difficulties, chest pain, and coughing, including coughing up blood in some cases. Cancer can also spread to bones, creating structural problems that may cause pain and reduce normal functioning. Other organs, including the liver, can be affected as well.

Even when sarcoma appears to have been completely removed through surgery, it has a frustrating tendency to come back. This recurrence can happen at the original site or in distant locations. Sarcomas are particularly known for this behavior, which is why long-term monitoring remains essential even years after successful treatment. Local recurrence at the surgical site can occur if microscopic cancer cells were left behind despite the surgeon's best efforts to remove all visible tumor tissue.

The treatments themselves can cause complications. Surgery for sarcoma, especially limb-sparing operations, can be extensive, involving significant cutting into tissue, bone, and muscle. This leaves patients with long scars and potential functional limitations. Some people experience chronic tightness and discomfort, particularly if radiation therapy was used in the same area, as radiation can make healthy tissues less flexible and stretchy over time.

Radiation therapy, while targeting cancer cells, can also affect nearby healthy tissues. This may lead to skin changes, fatigue, and damage to blood vessels or nerves in the treatment area. Long-term effects can include changes in skin texture, lymphatic system damage that leads to lymphedema (chronic swelling), and an increased risk of developing other cancers in the irradiated area years later.

Chemotherapy brings its own set of potential complications, including suppression of the bone marrow's ability to produce blood cells, which increases infection risk, causes anemia, and affects blood clotting. Digestive problems like nausea, vomiting, and diarrhea are common. Some chemotherapy drugs can damage nerves, leading to neuropathy—tingling, numbness, or pain in the hands and feet. Hair loss, fatigue, and "chemo brain" (difficulties with memory and concentration) can also occur.

For bone sarcomas or sarcomas requiring extensive surgery, there may be structural complications. Bones weakened by cancer can break unexpectedly, sometimes with minimal trauma or even spontaneously. After limb-sparing surgery or amputation, patients face the challenge of regaining mobility and adapting to changes in how their body moves and functions.

Infections represent another concern, particularly for patients whose immune systems are weakened by chemotherapy or who have surgical wounds. Fever, unusual bleeding, or signs of infection like redness, warmth, or drainage from surgical sites require immediate medical attention. Blood clots can form, especially in the legs, causing pain, redness, and swelling. If a clot breaks loose and travels to the lungs, it can cause a life-threatening pulmonary embolism.

Impact on Daily Life

Sarcoma affects far more than just physical health—it touches every aspect of daily living, from the most basic activities to social relationships, emotional well-being, and future plans. Understanding these impacts can help you and your loved ones prepare and find ways to adapt.

Physically, the effects can be substantial. A sarcoma in a limb may make walking, standing, or using your arms difficult, especially after surgery. Many patients struggle with moving the affected limb initially, though physiotherapy exercises gradually improve mobility over time. For some, it can take many months—sometimes up to a year—before they can comfortably bear significant weight or use a prosthetic limb effectively if amputation was necessary. Daily tasks that once seemed simple, like dressing, bathing, cooking, or climbing stairs, may require new approaches or assistive devices.

Pain can be a constant companion. The tumor itself may cause pain, particularly if it presses on nerves or bones. Treatment-related pain from surgery, radiation, or procedures is common. Managing this pain often requires a combination of medications, physical therapy, and sometimes complementary approaches like meditation or relaxation techniques. The good news is that pain from cancer and surgery can almost always be controlled with proper management—the key is communicating openly with your healthcare team about your pain levels.

Fatigue represents one of the most challenging aspects of living with sarcoma. This isn't ordinary tiredness that improves with rest—it's a deep, persistent exhaustion that can make even small activities feel overwhelming. Treatment, pain, stress, poor sleep, and the body's fight against cancer all contribute to this fatigue. Balancing activity with rest becomes essential, as does accepting that you may not be able to do everything you once did, at least temporarily.

Changes in appearance can profoundly affect self-esteem and social confidence. Surgery may leave visible scars, some quite extensive. For those who have had amputations, the loss of a limb changes not only function but also how they see themselves and how they believe others perceive them. These changes can create anxiety about social situations, returning to work, meeting new people, or going to job interviews. Some people feel they are no longer as physically attractive, which can strain existing relationships and make forming new ones feel daunting.

Emotional impacts run deep. Many patients experience a range of feelings: shock and disbelief upon diagnosis, fear about the future, anger at the unfairness of it all, guilt (particularly if they worry about burdening family), and sometimes depression or anxiety. These feelings are completely normal and natural responses to a serious illness. They may come and go in waves, intensifying at certain times like before scans or doctor appointments, or on anniversaries of diagnosis or treatment milestones.

Sexual health and intimacy can be affected, both physically and emotionally. Pain, fatigue, changes in body image, and the emotional burden of cancer can all reduce interest in sex and make physical intimacy uncomfortable or difficult. Partners may worry about causing pain or may not know how to navigate these changes. Open communication with your partner and healthcare team about these concerns is important but can feel awkward or embarrassing to initiate.

Work life often requires adjustments. Treatment schedules, fatigue, and physical limitations may make it impossible to maintain your usual work routine. Some people need extended medical leave, reduced hours, or modified duties. Financial concerns about income loss, coupled with mounting medical expenses, add another layer of stress. The Americans with Disabilities Act and similar laws in other countries provide some employment protections, but navigating these systems can be complex.

Social activities and hobbies may need to be adapted or temporarily set aside. If your sarcoma is in a leg, running or playing sports may be impossible during treatment and recovery. Hobbies requiring fine motor skills might be challenging if you have treatment-related neuropathy or if your sarcoma affected your arms or hands. Some people withdraw from social activities due to fatigue, appearance concerns, or simply feeling that others cannot understand what they're going through.

There are practical strategies that can help. Keeping organized with a dedicated binder for medical documents, appointment schedules, and contact information reduces stress and ensures important information is always at hand. Making lists, setting realistic goals, and planning enjoyable activities during weeks that might be emotionally or physically difficult can provide structure and things to look forward to. Many patients find that gentle physical activity, even just short walks when possible, helps with both physical recovery and emotional well-being.

Nutrition becomes more important than ever, though appetite and taste changes can make eating challenging. Focusing on foods with adequate protein and calories helps maintain strength. When eating solid food is difficult, liquid meal replacements can bridge the gap. If you experience nausea, vomiting, or diarrhea, staying hydrated with clear liquids is essential.

Many patients benefit from rehabilitation services. Physical therapists design exercises to restore movement and strength. Occupational therapists help you adapt daily activities and may recommend assistive devices. For those dealing with lymphedema, specialized therapists can teach management techniques. Speech therapists may help if your sarcoma affected areas involved in swallowing or speaking.

Support for Family: Navigating Clinical Trials Together

Families play a crucial role when a loved one has sarcoma, and this is especially true when considering participation in clinical trials—research studies that test new treatments or approaches to care. Understanding what clinical trials are and how families can support their loved one through this process is valuable knowledge.

Clinical trials represent hope for better treatments. Because sarcomas are rare, making up only about 1% of adult cancers and 15% of childhood cancers, there is an ongoing need for research to develop more effective therapies. Many patients with sarcoma, particularly those with advanced disease that hasn't responded to standard treatments, may benefit from clinical trials that offer access to cutting-edge therapies not yet available to the general public.

Families should understand that clinical trials are conducted under strict ethical guidelines and careful medical supervision. They go through multiple phases of testing to ensure safety and effectiveness. Participation is always voluntary, and patients can withdraw at any time without affecting their standard care. Not all trials involve experimental drugs—some study different combinations of existing treatments, compare treatment approaches, or investigate supportive care methods to manage side effects better.

When a loved one is considering a clinical trial, family members can help by participating in educational discussions with the healthcare team. Attend appointments when possible to hear information firsthand and ask questions. Two sets of ears are better than one when processing complex medical information. Write down questions before appointments and take notes during discussions. Understanding the trial's purpose, potential benefits, possible risks, what participation involves (such as additional appointments or tests), and whether there are any costs is essential.

Researching the trial together can be helpful, but families should rely on reputable sources. The treating physician, cancer center staff, and websites like ClinicalTrials.gov provide reliable information. Be cautious about information from random internet sources that may be inaccurate or misleading. Sarcoma-specific organizations often maintain databases of relevant clinical trials and can provide guidance.

Families can assist with practical aspects of trial participation. Clinical trials often require frequent visits to the medical center, which may involve travel if the trial is at a specialized sarcoma center some distance from home. Family members can help coordinate transportation, arrange accommodations if overnight stays are needed, and manage the logistics of scheduling around work, school, and other family obligations. Some organizations offer financial assistance for travel and lodging related to clinical trial participation.

Emotional support is perhaps the most important role families can play. Deciding whether to join a clinical trial can be stressful. Patients may feel uncertain, hopeful, anxious, or all of these at once. Family members can listen without judgment, validate these feelings, and remind their loved one that whatever decision they make is the right one for them. Avoid pushing in one direction or another—the choice must ultimately rest with the patient.

If the patient enrolls in a trial, families can help track appointments, medications, and any side effects or symptoms that arise. Some trials require detailed record-keeping, and having help with this can reduce the patient's burden. Be alert for any concerning symptoms and don't hesitate to contact the trial team if something seems wrong—clinical trial protocols typically include 24-hour contact information for urgent concerns.

It's important for families to understand that participating in a clinical trial doesn't mean giving up on other treatment options. If the trial treatment isn't working or causes unacceptable side effects, patients can discontinue participation and return to standard care. Additionally, being in a trial often means receiving extremely close monitoring and attention from a specialized medical team, which can be a benefit in itself.

Families should also be aware that not everyone qualifies for every trial. Clinical trials have specific eligibility criteria—requirements related to the type and stage of cancer, previous treatments, overall health, and other factors. If your loved one doesn't qualify for one trial, there may be others that are appropriate, or new trials may open in the future. Many sarcoma centers maintain lists of patients interested in trials and will reach out when appropriate studies become available.

Communication with the rest of the family and friends is another area where close family members can help. The patient may not have the energy to update everyone repeatedly, so designating a family member to share updates through a group email, text chain, or online platform like CaringBridge can reduce this burden. This also ensures everyone receives accurate, consistent information.

Finally, families shouldn't neglect their own needs. Supporting someone through sarcoma treatment, with or without a clinical trial, is demanding. Family members may experience their own stress, fear, fatigue, and emotional challenges. Taking breaks, seeking support from friends or counselors, and maintaining some normal routines and activities helps caregivers sustain themselves for the long haul. Many cancer centers offer support services specifically for family members and caregivers.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Denosumab (Xgeva®) – A monoclonal antibody that targets the RANKL pathway; approved for subsets of patients with bone cancer
  • Atezolizumab (Tecentriq®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with alveolar soft part sarcoma
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced sarcoma that has DNA mismatch repair deficiency
  • Pembrolizumab (Keytruda®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced sarcoma that has high microsatellite instability, DNA mismatch repair deficiency, or high tumor mutational burden

Did you know?

  1. Sarcomas are one of the few cancers that were documented in ancient times—spontaneous regression cases (where the cancer disappeared without treatment) were among the earliest known instances of cancer remission recorded in medical history.
  2. While sarcomas make up only 1% of adult cancers, they account for approximately 15% of childhood cancers, making them relatively much more common in young people than in adults.
  3. There are more than 70 different subtypes of sarcoma, each named and classified based on the specific type of tissue they resemble—from liposarcoma that resembles fat tissue to leiomyosarcoma that looks like smooth muscle.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Sarcoma

Recruiting trials first

See all 11 trials →
Quick filters

11 clinical trials in this condition

Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Zanidatamab
  • Sponsor:Unicancer
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bay 2927088
  • Sponsor:Bayer AG

Sarcoma

Recruiting
Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Cart45Ra-Nkg2D Cells
  • Sponsor:Hospital Universitario La Paz

Sarcoma

Recruiting
Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allogeneic Peripheral Blood-Derived Cd56+ Natural Killer Cells, Co-Cultured With K562-Mb15-41Bbi Cell Line
  • Sponsor:Hospital Universitario La Paz
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Trabectedin
  • Sponsor:Asoc Grupo Espanol De Investigacion En Sarcomas
See all 11 trials →filters applied: condition = Sarcoma

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).